|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Abetalipoproteinemia | |||||
| 2 | More general conditions related to this trial | ||||
| Dyslipidemias | |||||
| Genetic Diseases, Inborn | |||||
| Hypobetalipoproteinemias | |||||
| Hypolipoproteinemias | |||||
| Lipid Metabolism Disorders | |||||
| Lipid Metabolism, Inborn Errors | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| 3 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||